chr8-125431086-C-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_025195.4(TRIB1):c.184C>A(p.Pro62Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000785 in 1,389,282 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P62S) has been classified as Uncertain significance.
Frequency
Consequence
NM_025195.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
TRIB1 | NM_025195.4 | c.184C>A | p.Pro62Thr | missense_variant | 1/3 | ENST00000311922.4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
TRIB1 | ENST00000311922.4 | c.184C>A | p.Pro62Thr | missense_variant | 1/3 | 1 | NM_025195.4 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000921 AC: 14AN: 152016Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000989 AC: 2AN: 20220Hom.: 0 AF XY: 0.000160 AC XY: 2AN XY: 12470
GnomAD4 exome AF: 0.0000768 AC: 95AN: 1237266Hom.: 0 Cov.: 29 AF XY: 0.0000743 AC XY: 45AN XY: 605444
GnomAD4 genome AF: 0.0000921 AC: 14AN: 152016Hom.: 0 Cov.: 33 AF XY: 0.000121 AC XY: 9AN XY: 74268
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 09, 2022 | The c.184C>A (p.P62T) alteration is located in exon 1 (coding exon 1) of the TRIB1 gene. This alteration results from a C to A substitution at nucleotide position 184, causing the proline (P) at amino acid position 62 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at